Riichiro Abe

10.8k total citations · 3 hit papers
167 papers, 6.5k citations indexed

About

Riichiro Abe is a scholar working on Immunology, Pharmacology and Dermatology. According to data from OpenAlex, Riichiro Abe has authored 167 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Immunology, 35 papers in Pharmacology and 35 papers in Dermatology. Recurrent topics in Riichiro Abe's work include Drug-Induced Adverse Reactions (33 papers), Autoimmune Bullous Skin Diseases (24 papers) and Macrophage Migration Inhibitory Factor (21 papers). Riichiro Abe is often cited by papers focused on Drug-Induced Adverse Reactions (33 papers), Autoimmune Bullous Skin Diseases (24 papers) and Macrophage Migration Inhibitory Factor (21 papers). Riichiro Abe collaborates with scholars based in Japan, United States and China. Riichiro Abe's co-authors include Hiroshi Shimizu, Tadamichi Shimizu, Christine N. Metz, Yasuyuki Fujita, Tina Peng, Richard Bucala, Seamas C. Donnelly, Mikako Sasaki, Daisuke Inokuma and Sho‐ichi Yamagishi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Riichiro Abe

154 papers receiving 6.3k citations

Hit Papers

Peripheral Blood Fibrocytes: Differentiation Pathway and ... 2001 2026 2009 2017 2001 2008 2022 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Riichiro Abe Japan 40 1.6k 1.5k 912 887 876 167 6.5k
Yuji Shirakata Japan 36 1.1k 0.7× 1.3k 0.9× 578 0.6× 830 0.9× 563 0.6× 96 4.7k
Yasuyuki Fujita Japan 33 666 0.4× 1.2k 0.8× 280 0.3× 333 0.4× 726 0.8× 178 4.5k
Alain Mauviel France 64 1.2k 0.7× 6.3k 4.1× 323 0.4× 960 1.1× 361 0.4× 145 11.2k
Alan T. Nurden France 60 1.4k 0.9× 2.0k 1.3× 308 0.3× 191 0.2× 1.4k 1.6× 278 14.5k
Brygida Berse United States 39 835 0.5× 6.3k 4.1× 525 0.6× 330 0.4× 461 0.5× 70 10.0k
S. Joseph Leibovich United States 37 2.5k 1.6× 2.9k 1.9× 292 0.3× 286 0.3× 449 0.5× 73 9.1k
Edward P. Amento United States 43 1.8k 1.1× 2.3k 1.5× 217 0.2× 298 0.3× 212 0.2× 78 8.2k
Ralf J. Ludwig Germany 45 1.7k 1.1× 1.1k 0.7× 254 0.3× 975 1.1× 2.6k 3.0× 309 7.3k
Jochen Zwerina Austria 64 2.3k 1.4× 4.9k 3.2× 657 0.7× 545 0.6× 732 0.8× 229 12.2k
George Bou–Gharios United Kingdom 44 578 0.4× 3.4k 2.2× 129 0.1× 381 0.4× 834 1.0× 158 6.6k

Countries citing papers authored by Riichiro Abe

Since Specialization
Citations

This map shows the geographic impact of Riichiro Abe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Riichiro Abe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Riichiro Abe more than expected).

Fields of papers citing papers by Riichiro Abe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Riichiro Abe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Riichiro Abe. The network helps show where Riichiro Abe may publish in the future.

Co-authorship network of co-authors of Riichiro Abe

This figure shows the co-authorship network connecting the top 25 collaborators of Riichiro Abe. A scholar is included among the top collaborators of Riichiro Abe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Riichiro Abe. Riichiro Abe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Hayashi, Ryota, Tatsuya Takenouchi, Kazuaki Suda, et al.. (2024). Reevaluating hybrid neurofibroma/schwannoma: Predominance of schwannoma features despite CD34 positivity and initial neurofibroma diagnosis. The Journal of Dermatology. 51(11). 1461–1469. 3 indexed citations
4.
Fujimoto, Atsushi, Ryota Hayashi, Seitaro Iguchi, & Riichiro Abe. (2024). Can dermatologists reach their full potential in teledermatology? A validation study of diagnostic performance of skin diseases in live video conferencing teledermatology. The Journal of Dermatology. 51(7). 991–998.
5.
Hayashi, Ryota, et al.. (2024). Widespread imiquimod-induced psoriasis-like eruption: case report and analysis of mast cell infiltration. Clinical and Experimental Dermatology. 50(6). 1221–1224.
7.
Hirai, Yoji, Shiho Yoshida, Toshiharu Mitsuhashi, et al.. (2024). Phase I/II clinical trial of brentuximab vedotin for pretreated Japanese patients with CD30‐positive cutaneous T‐cell lymphoma. The Journal of Dermatology. 51(8). 1037–1049. 1 indexed citations
8.
Hayashi, Ryota, Akito Hasegawa, Takashi Ariizumi, et al.. (2023). Deep dermatophytosis caused by Trichophyton rubrum in an elderly patient with CARD9 deficiency: A case report and literature review. The Journal of Dermatology. 51(2). 294–300. 2 indexed citations
10.
Sproule, Thomas J., Robert Y Wilpan, John J. Wilson, et al.. (2023). Dystonin modifiers of junctional epidermolysis bullosa and models of epidermolysis bullosa simplex without dystonia musculorum. PLoS ONE. 18(10). e0293218–e0293218. 1 indexed citations
11.
Abe, Riichiro, et al.. (2022). Diagnostic accuracy of dermoscopy for 934 basal cell carcinomas: A single‐center retrospective study. The Journal of Dermatology. 50(1). 64–71. 7 indexed citations
12.
Hasegawa, Akito, Natsumi Hama, Haruto Nishida, et al.. (2021). A case of Stevens–Johnson syndrome‐like eruption suggesting clinical importance of body temperature and serum levels of receptor‐interacting kinase 3. Journal of Cutaneous Immunology and Allergy. 4(6). 184–186.
13.
Kinoshita, Manao, Youichi Ogawa, Natsumi Hama, et al.. (2021). Neutrophils initiate and exacerbate Stevens-Johnson syndrome and toxic epidermal necrolysis. Science Translational Medicine. 13(600). 53 indexed citations
14.
Hasegawa, Akito, Ryota Hayashi, Yutaka Shimomura, Masanori Hirashima, & Riichiro Abe. (2021). Only plantar lesion of punctate palmoplantar keratoderma with a novel missense mutation in the AAGAB gene: Two Japanese familial case reports and review of reported mutations. The Journal of Dermatology. 48(12). 1926–1930. 1 indexed citations
15.
Sakamoto, R., Ikko Kajihara, Soichiro Sawamura, et al.. (2020). Inhibition of Endoglin Exerts Antitumor Effects through the Regulation of Non-Smad TGF-β Signaling in Angiosarcoma. Journal of Investigative Dermatology. 140(10). 2060–2072.e6. 7 indexed citations
16.
Fujita, Yasuyuki, Satoru Shinkuma, Shotaro Suzuki, et al.. (2019). Cultured Epidermal Autografts from Clinically Revertant Skin as a Potential Wound Treatment for Recessive Dystrophic Epidermolysis Bullosa. Journal of Investigative Dermatology. 139(10). 2115–2124.e11. 19 indexed citations
17.
Abe, Riichiro. (2014). Immunological response in Stevens–Johnson syndrome and toxic epidermal necrolysis. The Journal of Dermatology. 42(1). 42–48. 33 indexed citations
18.
Nomura, Yukiko, Toshifumi Nomura, Kaori Sakai, et al.. (2012). A novel splice site mutation in NCSTN underlies a Japanese family with hidradenitis suppurativa. British Journal of Dermatology. 168(1). 206–209. 35 indexed citations
19.
Fujita, Yasuyuki, Riichiro Abe, Daisuke Inokuma, et al.. (2010). Bone marrow transplantation restores epidermal basement membrane protein expression and rescues epidermolysis bullosa model mice. Proceedings of the National Academy of Sciences. 107(32). 14345–14350. 48 indexed citations
20.
Hoshina, Daichi, Riichiro Abe, Sho‐ichi Yamagishi, & Hiroaki Shimizu. (2010). The Role of PEDF in Tumor Growth and Metastasis. Current Molecular Medicine. 10(3). 292–295. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026